Trial intelligence / Profile preview

Methylergonovine Prophylaxis After Dilation and Evacuation Abortion

NCT02408965Phase 4Completed

Sponsor
University of California, San Francisco
Start
Mar 2015
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylergometrine in hemorrhage, sponsored by University of California, San Francisco. Started Mar 2015; status: completed.

02

Drugs

methylergometrine
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT02408965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02408965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call